Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 41351-41400 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05756426
Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy
N/ARecruiting
250 participants
Started: Apr 13, 2023 · Completed: Jan 30, 2029
2 conditions2 sponsors1 location
NCT05721599
Effectiveness of Integrated Care Combined Nutrition and Lifestyle Counselling in Frail Older Patients With Diabetes
NARecruiting
100 participants
Started: Apr 13, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05538247
Saccharomyces Boulardii CNCM I-745 on Intestinal Barrier Function
EARLY_PHASE1Recruiting
56 participants
Started: Apr 13, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06202261
A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
PHASE1/PHASE2Recruiting
154 participants
Started: Apr 13, 2023 · Completed: Oct 31, 2027
3 conditions1 sponsor2 locations
NCT05759988
Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)
NARecruiting
2,300 participants
Started: Apr 13, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor4 locations
NCT05820074
Investigating Neural Biomarkers for Gait in Parkinson's Patients
N/ARecruiting
60 participants
Started: Apr 13, 2023 · Completed: Mar 31, 2025
2 conditions3 sponsors1 location
NCT05296720
EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia
NARecruiting
68 participants
Started: Apr 13, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05593146
A Randomized Controlled Study Evaluating Modified Cup Anteversion Placement in Prevention of Postoperative Dislocation in Patients Undergoing Acetabular Tumor Resection and Reconstruction
PHASE2Recruiting
118 participants
Started: Apr 13, 2023 · Completed: Jun 1, 2028
1 condition1 sponsor1 location
NCT05686759
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
PHASE3Recruiting
105 participants
Started: Apr 13, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor8 locations
NCT05746897
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
PHASE1Recruiting
38 participants
Started: Apr 13, 2023 · Completed: Sep 30, 2027
4 conditions1 sponsor2 locations
NCT06562647
SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
NARecruiting
2 participants
Started: Apr 12, 2023 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT06685796
A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer
PHASE2Recruiting
120 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05482789
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
PHASE4Recruiting
13 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06708780
Immunotherapy with Autologous Tregs in T1DM
PHASE1Recruiting
20 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT04478734
Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease
PHASE2Recruiting
24 participants
Started: Apr 12, 2023 · Completed: Dec 30, 2025
1 condition2 sponsors3 locations
NCT05843019
Adherence in Global Airways - Steroid Intake and Effects on Chronic Rhinosinosinutis
N/ARecruiting
80 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05012033
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
N/ARecruiting
120 participants
Started: Apr 12, 2023 · Completed: Mar 26, 2026
5 conditions1 sponsor1 location
NCT05691647
Chronotherapy for Depressive Episodes
NARecruiting
76 participants
Started: Apr 12, 2023 · Completed: Jan 31, 2040
1 condition1 sponsor1 location
NCT07135011
Adaptive Study to Assess the Safety and Functioning of Motiva Devices on Minimally Invasive Gluteal Augmentation
NARecruiting
120 participants
Started: Apr 12, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05792189
Distal Femur Fx: ORIF(Open Reduction and Internal Fixation) vs DFR (Distal Femur Replacement Total Knee Arthroplasty)
NARecruiting
100 participants
Started: Apr 12, 2023 · Completed: Apr 1, 2029
1 condition1 sponsor1 location
NCT05822037
CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NARecruiting
6 participants
Started: Apr 12, 2023 · Completed: Apr 29, 2026
2 conditions2 sponsors1 location
NCT05878002
"Cognitive, Motor and Sleep Evaluation in Patients With Ischemic Stroke of Basal Ganglia After Thrombectomy"
NARecruiting
300 participants
Started: Apr 12, 2023 · Completed: Apr 30, 2034
1 condition1 sponsor1 location
NCT05534386
A Self-management Based Survivorship Intervention for Chinese Cancer Survivors
NARecruiting
486 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor7 locations
NCT05511246
Venous Ethanol for Ventricular Tachycardia
PHASE2Recruiting
156 participants
Started: Apr 12, 2023 · Completed: Dec 12, 2028
2 conditions1 sponsor1 location
NCT05564026
Molecular Epidemiology of Pediatric Germ Cell Tumors
N/ARecruiting
1,151 participants
Started: Apr 12, 2023 · Completed: Jun 30, 2027
9 conditions1 sponsor1 location
NCT05748873
Promising ROd-cone DYstrophy Gene therapY
PHASE1/PHASE2Recruiting
33 participants
Started: Apr 12, 2023 · Completed: Sep 30, 2030
1 condition1 sponsor6 locations
NCT05364970
IVR in Motor Rehabilitation
EARLY_PHASE1Recruiting
45 participants
Started: Apr 12, 2023 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT04728516
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
PHASE4Recruiting
2,600 participants
Started: Apr 12, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor42 locations
NCT05619289
Immune Mechanisms of Vitamin D to Reduce Chronic Pain After Burn
PHASE2Recruiting
40 participants
Started: Apr 12, 2023 · Completed: Feb 1, 2026
2 conditions2 sponsors1 location
NCT05832736
Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer
NARecruiting
36 participants
Started: Apr 12, 2023 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT05805722
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
NARecruiting
75 participants
Started: Apr 12, 2023 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT05682144
ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I
PHASE1Recruiting
2 participants
Started: Apr 12, 2023 · Completed: Jun 1, 2039
2 conditions1 sponsor2 locations
NCT05724836
Prospective Carotid Artery Stenosis Trial
N/ARecruiting
200 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT05661201
NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors
PHASE1Recruiting
24 participants
Started: Apr 12, 2023 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT05562492
Closed-loop for People Living with Cystic Fibrosis Related Diabetes
NARecruiting
128 participants
Started: Apr 12, 2023 · Completed: Oct 31, 2026
1 condition3 sponsors9 locations
NCT05893693
Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NARecruiting
12 participants
Started: Apr 12, 2023 · Completed: Jan 1, 2026
2 conditions2 sponsors1 location
NCT05908149
Gait Analysis in Patients With Hemiplegia Using Insole Splint.
NARecruiting
12 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06191640
Sinus Disease in Young Children With Cystic Fibrosis
N/ARecruiting
80 participants
Started: Apr 12, 2023 · Completed: Apr 30, 2026
5 conditions8 sponsors6 locations
NCT05420935
Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room
NARecruiting
40 participants
Started: Apr 12, 2023 · Completed: Dec 15, 2033
4 conditions2 sponsors1 location
NCT05778604
Optimizing a Technology-based Body and Mind Intervention
NARecruiting
340 participants
Started: Apr 12, 2023 · Completed: Jun 30, 2026
4 conditions2 sponsors1 location
NCT05730933
An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.
NARecruiting
72 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06141226
Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer
PHASE2Recruiting
148 participants
Started: Apr 12, 2023 · Completed: Dec 30, 2028
1 condition1 sponsor5 locations
NCT05685173
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
PHASE1Recruiting
91 participants
Started: Apr 12, 2023 · Completed: May 16, 2029
1 condition1 sponsor20 locations
NCT05673915
Study of Transcranial Direct Current Stimulation to Treat Epilepsy
NARecruiting
30 participants
Started: Apr 12, 2023 · Completed: Feb 28, 2026
3 conditions1 sponsor1 location
NCT05780892
Keck Medicine of University of Southern California Thrive Study
NARecruiting
400 participants
Started: Apr 12, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05909293
Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission
NARecruiting
100 participants
Started: Apr 12, 2023 · Completed: May 30, 2028
1 condition3 sponsors1 location
NCT06093204
The Potential Role of Compounds Derived From Ultra-processed Foods in Pathogenesis of Eosinophilic Esophagitis
N/ARecruiting
100 participants
Started: Apr 12, 2023 · Completed: Jun 12, 2026
1 condition1 sponsor2 locations
NCT05743283
Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds
NARecruiting
100 participants
Started: Apr 12, 2023 · Completed: Sep 30, 2025
1 condition3 sponsors2 locations
NCT05630586
Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
PHASE2Recruiting
380 participants
Started: Apr 12, 2023 · Completed: Dec 31, 2027
1 condition7 sponsors1 location
NCT05568069
RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure
NARecruiting
2,504 participants
Started: Apr 12, 2023 · Completed: Apr 1, 2036
1 condition3 sponsors47 locations